 |
autologous genetically modified human dermal fibroblasts |
|---|---|
| Trade Name | |
| Orphan Indication | Dystrophic epidermolysis bullosa |
| USA Market Approval | USA |
| USA Designation Date | 2014-06-10 00:00:00 |
| Sponsor | Fibrocell Technologies, Inc.;405 Eagleview Blvd;Exton, Pennsylvania, 19341 |
